USD 3.21
(-2.58%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 5.66 Million USD | -34.11% |
2022 | 8.59 Million USD | 53.14% |
2021 | 5.61 Million USD | 109.72% |
2020 | 2.67 Million USD | -41.92% |
2019 | 4.6 Million USD | 115.84% |
2018 | 2.13 Million USD | 159.61% |
2017 | 822 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 4.69 Million USD | -5.65% |
2024 Q1 | 4.97 Million USD | -12.12% |
2023 Q1 | 5.51 Million USD | -35.78% |
2023 Q4 | 5.66 Million USD | -31.17% |
2023 Q2 | 4.77 Million USD | -13.52% |
2023 FY | 5.66 Million USD | -34.11% |
2023 Q3 | 8.22 Million USD | 72.4% |
2022 Q3 | 5.86 Million USD | -9.88% |
2022 FY | 8.59 Million USD | 53.14% |
2022 Q1 | 4.81 Million USD | -14.12% |
2022 Q4 | 8.59 Million USD | 46.5% |
2022 Q2 | 6.5 Million USD | 35.06% |
2021 Q1 | 2.02 Million USD | -24.19% |
2021 FY | 5.61 Million USD | 109.72% |
2021 Q4 | 5.61 Million USD | 46.82% |
2021 Q3 | 3.82 Million USD | -47.81% |
2021 Q2 | 7.32 Million USD | 261.0% |
2020 Q2 | 3.25 Million USD | -17.02% |
2020 Q1 | 3.91 Million USD | -14.92% |
2020 FY | 2.67 Million USD | -41.92% |
2020 Q4 | 2.67 Million USD | 1.52% |
2020 Q3 | 2.63 Million USD | -18.97% |
2019 Q4 | 4.6 Million USD | 133.93% |
2019 Q3 | 1.96 Million USD | 21.17% |
2019 Q1 | 2.24 Million USD | 5.2% |
2019 Q2 | 1.62 Million USD | -27.62% |
2019 FY | 4.6 Million USD | 115.84% |
2018 FY | 2.13 Million USD | 159.61% |
2018 Q4 | 2.13 Million USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 FY | 822 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | -Infinity% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | -1615.314% |
Aspira Women's Health Inc. | 227 Thousand USD | -2393.833% |
Biodesix, Inc. | 1.4 Million USD | -304.357% |
BioNexus Gene Lab Corp. | 1.13 Million USD | -397.552% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -30526.488% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -30526.488% |
Bionano Genomics, Inc. | 22.89 Million USD | 75.272% |
CareDx, Inc | 19.47 Million USD | 70.926% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 7.94 Million USD | 28.721% |
DarioHealth Corp. | 5.06 Million USD | -11.833% |
Exact Sciences Corporation | 127.47 Million USD | 95.559% |
Fulgent Genetics, Inc. | 5.82 Million USD | 2.849% |
Guardant Health, Inc. | 61.94 Million USD | 90.862% |
ICON Public Limited Company | 1.00 USD | -566099900.0% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 98.511% |
Illumina, Inc. | 587 Million USD | 99.036% |
Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -628.068% |
iSpecimen Inc. | - USD | -Infinity% |
Standard BioTools Inc. | 20.53 Million USD | 72.43% |
MDxHealth SA | 2.77 Million USD | -103.706% |
23andMe Holding Co. | 12.46 Million USD | 54.585% |
Medpace Holdings, Inc. | 1.00 USD | -566099900.0% |
Myriad Genetics, Inc. | 20.1 Million USD | 71.836% |
Mainz Biomed B.V. | 613.63 Thousand USD | -822.531% |
ENDRA Life Sciences Inc. | 2.62 Million USD | -115.833% |
NeoGenomics, Inc. | 24.15 Million USD | 76.565% |
Neogen Corporation | 189.26 Million USD | 97.009% |
Inotiv, Inc. | 56.1 Million USD | 89.909% |
Natera, Inc. | 40.75 Million USD | 86.111% |
OpGen, Inc. | 1.00 USD | -566099900.0% |
OPKO Health, Inc. | 65.69 Million USD | 91.383% |
Psychemedics Corporation | 1.00 USD | -566099900.0% |
Prenetics Global Limited | 3.12 Million USD | -81.049% |
Prenetics Global Limited | 3.12 Million USD | -81.049% |
Precipio, Inc. | 384 Thousand USD | -1374.219% |
RadNet, Inc. | 1.00 USD | -566099900.0% |
Sera Prognostics, Inc. | - USD | -Infinity% |
Sotera Health Company | 51.98 Million USD | 89.11% |
Neuronetics, Inc. | 8.09 Million USD | 30.051% |
Star Equity Holdings, Inc. | 3.42 Million USD | -65.526% |
Star Equity Holdings, Inc. | 3.42 Million USD | -65.526% |
Trinity Biotech plc | 19.93 Million USD | 71.6% |
T2 Biosystems, Inc. | 4.81 Million USD | -17.473% |
Twist Bioscience Corporation | 32.06 Million USD | 82.344% |
Exagen Inc. | 2.87 Million USD | -97.179% |